Hormone restrains growth of liver tumors in mice, offers therapeutic targets University of Michigan researchers have identified in a mouse study a hormone -- neuregulin 4 -- that serves as a checkpoint for the progression of nonalcoholic steatohepatitis and appears to have potential as a treatment for hepatocellular carcinoma, the most common type of primary liver cancer.Read More